Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013
MetadataShow full item record
A total of 9599 isolates of Gram-negative bacteria (GNB) causing urinary tract infections (UTIs) were collected from 60 centres in 13 countries in the Asia-Pacific region from 2010-2013. These isolates comprised Enterobacteriaceae species (mainly Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Klebsiella oxytoca, Enterobacter cloacae and Morganella morganii) and non-fermentative GNB species (predominantly Pseudomonas aeruginosa and Acinetobacter baumannii). In vitro susceptibilities were determined by the agar dilution method and susceptibility profiles were determined using the minimum inhibitory concentration (MIC) interpretive breakpoints recommended by the Clinical and Laboratory Standards Institute in 2015. Production of extended-spectrum ß-lactamases (ESBLs) amongst E. coli, K. pneumoniae, P. mirabilis and K. oxytoca isolates was determined by the double-disk synergy test. China, Vietnam, India, Thailand and the Philippines had the highest rates of GNB species producing ESBLs and the highest rates of cephalosporin resistance. ESBL production and hospital-acquired infection (isolates obtained =48 h after admission) significantly compromised the susceptibility of isolates of E. coli and K. pneumoniae to ciprofloxacin, levofloxacin and most ß-lactams, with the exception of imipenem and ertapenem. However, > 87% of ESBL-producing E. coli strains were susceptible to amikacin and piperacillin/tazobactam, indicating that these antibiotics might be appropriate alternatives for treating UTIs due to ESBL-producing E. coli. Fluoroquinolones were shown to be inappropriate as empirical therapy for UTIs. Antibiotic resistance is a serious problem in the Asia-Pacific region. Therefore, continuous monitoring of evolutionary trends in the susceptibility profiles of GNB causing UTIs in Asia is crucial.
Showing items related by title, author, creator and subject.
Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010–2013Chang, Y.; Coombs, Geoffrey; Ling, T.; Balaji, V.; Rodrigues, C.; Mikamo, H.; Kim, M.; Rajasekaram, D.; Mendoza, M.; Tan, T.; Kiratisin, P.; Ni, Y.; Barry, W.; Xu, Y.; Chen, Y.; Hsueh, P. (2017)This study was conducted to investigate the epidemiology and antimicrobial susceptibility patterns of Gram-negative bacilli (GNB) isolated from intra-abdominal infections (IAIs) in the Asia-Pacific region (APR) from ...
Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008–14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)Jean, S.; Hsueh, P.; Korman, T.; Ellem, J.; George, N.; Coombs, Geoffrey; Ling, T.; Tsang, O.; Balaji, V.; Mikamo, H.; Kusachi, S.; Mizutani, T.; Kim, M.; Bae, I.; Umur, N.; Rajasekaram, D.; Taylor, S.; Roberts, S.; van der Werff, K.; Drinkovic, D.; Lagamayo, E.; Mendoza, M.; Tan, T.; Krishnan, P.; Wang, E.; Lu, P.; Liu, C.; Chuang, K.; Yu, K.; Chen, Y.; Lu, M.; Panthuwong, S.; Kiratisin, P.; Phoung, N.; Phuong, D.; Van, N.; Nga, T. (2017)Objectives: To investigate the antimicrobial resistance and assess the molecular characteristics of β-lactamases (ESBLs, AmpC β-lactamases and carbapenemases) among Enterobacteriaceae isolates that caused intra-abdominal ...
Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: Electronic database study in Oxfordshire 1999-2011Schlackow, I.; Stoesser, N.; Walker, A.; Crook, D.; Peto, T.; Wyllie, D.; Bejon, P.; Berendt, T.; Bunch, C.; Finney, J.; Gearing, J.; Jones, H.; O'Connor, L.; Robinson, James; Shine, B.; Waller, D. (2012)Objectives: To investigate trends in Escherichia coli resistance, bacteraemia rates and post-bacteraemia outcomes over time. Methods: Trends in E. coli bacteraemia incidence were monitored from January 1999 to June 2011 ...